Gender Disparities on the Use and Outcomes of Mechanical Circulatory Support in Patients With Cardiogenic Shock

Carlos Diaz-Arocutipa1, Norma Nicole Gamarra-Valverde2, Rafael Salguero3

  • 1Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.

PubMed

Insights

Women with cardiogenic shock after heart attack receive less mechanical circulatory support (MCS) and have higher mortality. Racial disparities also limit MCS use, highlighting inequities in care.

Area of Science:

  • Cardiology
  • Health Services Research
  • Health Equity

Background:

  • Cardiogenic shock complicating acute myocardial infarction (AMI-CS) is a severe condition with high mortality.
  • Despite treatment advances, gender and racial disparities in managing AMI-CS persist.

Purpose of the Study:

  • To investigate gender differences in mechanical circulatory support (MCS) utilization and outcomes for AMI-CS.
  • To examine AMI-CS management strategies stratified by race/ethnicity.

Main Methods:

  • Retrospective analysis of the National Inpatient Sample (2016-2019) for AMI-CS admissions.
  • Inverse probability of treatment weighting (IPTW) used to compare MCS use and outcomes between genders.
  • Odds ratios (OR) and 95% confidence intervals (CI) calculated.

Main Results:

  • Analysis included 151,560 AMI-CS admissions (98,855 males, 52,705 females).
  • Females were less likely to receive MCS (OR 0.77, 95% CI 0.73-0.81) and had higher in-hospital mortality (OR 1.09, 95% CI 1.00-1.18) post-IPTW adjustment.
  • Racial disparities showed lower MCS utilization in female patients across all groups compared to males; Black and Hispanic patients had lower MCS use than White patients.

Conclusions:

  • Significant gender disparities exist in MCS utilization and outcomes for AMI-CS patients.
  • Female patients and racial minorities face barriers to MCS, contributing to poorer outcomes.
  • Findings highlight the intersection of gender, race, and healthcare access in AMI-CS management.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
758
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2